New drug-eluting stents: polymer-free, biodegradable polymers or bioabsorbable scaffolds?
Unidad de Hemodinámica, Instituto Cardiovascular, Hospital Universitario Clínico San Carlos, IdISSC, Madrid, Spain. Electronic address: falf@hotmail.com.
Fernando
F
Alfonso
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000627:therapeutic use*; D003327:Coronary Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage* / Q000627:therapeutic use*; D020123:Sirolimus / Q000008:administration & dosage* / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; D007166:Immunosuppressive Agents; D017239:Paclitaxel; D020123:Sirolimus